Esmolol: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - " ==" to "==") |
Elcatracho (talk | contribs) |
||
| (8 intermediate revisions by 7 users not shown) | |||
| Line 2: | Line 2: | ||
*Type: [[Beta blockers]] | *Type: [[Beta blockers]] | ||
*Dosage Forms: | *Dosage Forms: | ||
*Common Trade Names: | *Common Trade Names: Brevibloc | ||
==Adult Dosing== | ==Adult Dosing== | ||
*Loading dose = 500mcg/kg bolus over 1min | *Loading dose = 500mcg/kg bolus over 1min | ||
**Follow this | **Follow this with infusion at 50mcg/kg/min for 4min | ||
***If no response give another 500 bolus, | ***If no response give another 500 bolus, increased infusion to 100 | ||
***If no response give another 500 bolus, | ***If no response give another 500 bolus, increased infusion to 200 | ||
*Symptomatic AAA (controversial) | |||
**500mcg/kg bolus | |||
**Infusion of 50-200mcg/kg/min titrated to goal SBP | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | ||
*Lactation: | *Lactation: Unknown if excreted in breast milk | ||
*Renal Dosing | *Renal Dosing | ||
**Adult | **Adult: No adjustment required | ||
*Hepatic Dosing | *Hepatic Dosing | ||
**Adult | **Adult: No adjustment required | ||
==Contraindications== | ==Contraindications== | ||
| Line 29: | Line 31: | ||
==Indications== | ==Indications== | ||
*Supraventricular arrhythmias | *Supraventricular arrhythmias | ||
*Heart rate and blood pressure control in Symptomatic Aortic Aneurysm (titrate to HR <60 bmp) | |||
*Off label use: refractory [[VF]] | |||
==Adverse Reactions== | ==Adverse Reactions== | ||
| Line 35: | Line 39: | ||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: | *Half-life: Adults - 9min Children 18mo-16yrs 2.7-4.8min | ||
*Metabolism: | *Metabolism: Red Blood Cell Esterase | ||
*Excretion: | *Excretion: Renal | ||
*Mechanism of Action: Class II - Short-acting Beta1 blocker | *Mechanism of Action: Class II - Short-acting Beta1 blocker | ||
*Onset of action = 1-4min | *Onset of action = 1-4min | ||
| Line 43: | Line 47: | ||
==See Also== | ==See Also== | ||
*[[Beta-blockers]] | |||
*[[Beta-blocker toxicity]] | |||
*[[Antiarrhythmics]] | *[[Antiarrhythmics]] | ||
*[[Antihypertensive medications]] | |||
==References== | ==References== | ||
<references/> | |||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Cardiology]] | |||
[[Category:Critical Care]] | |||
Latest revision as of 01:25, 7 March 2021
General
- Type: Beta blockers
- Dosage Forms:
- Common Trade Names: Brevibloc
Adult Dosing
- Loading dose = 500mcg/kg bolus over 1min
- Follow this with infusion at 50mcg/kg/min for 4min
- If no response give another 500 bolus, increased infusion to 100
- If no response give another 500 bolus, increased infusion to 200
- Follow this with infusion at 50mcg/kg/min for 4min
- Symptomatic AAA (controversial)
- 500mcg/kg bolus
- Infusion of 50-200mcg/kg/min titrated to goal SBP
Pediatric Dosing
Special Populations
- Pregnancy Rating: C
- Lactation: Unknown if excreted in breast milk
- Renal Dosing
- Adult: No adjustment required
- Hepatic Dosing
- Adult: No adjustment required
Contraindications
- Allergy to class/drug
- Cardiogenic shock
- 2nd or 3rd AV block
Indications
- Supraventricular arrhythmias
- Heart rate and blood pressure control in Symptomatic Aortic Aneurysm (titrate to HR <60 bmp)
- Off label use: refractory VF
Adverse Reactions
- Hypotension
- Bronchospasm
Pharmacology
- Half-life: Adults - 9min Children 18mo-16yrs 2.7-4.8min
- Metabolism: Red Blood Cell Esterase
- Excretion: Renal
- Mechanism of Action: Class II - Short-acting Beta1 blocker
- Onset of action = 1-4min
- Duration of action = <30min